Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsa Kalbacher

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Thrombolysis|June 6, 2018
Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse eventsRomain Chopard, Guillaume Serzian, Sébastien Humbert, et al.
Medical Oncology (Northwood, London, England)|March 27, 2012
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumorsAntoine Adenis, Olivier Bouché, François Bertucci, et al.
Thrombosis Research|December 16, 2018
Prescription patterns of direct oral anticoagulants in pulmonary embolism: A prospective multicenter French registryRomain Chopard, Jean Noel Andarelli, Sébastien Humbert, et al.
Annals of Surgical Oncology|January 7, 2022
Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 PatientsBrice Paquette, Elsa Kalbacher, Frédéric Mercier, et al.
Cancer|November 3, 2011
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomasAntoine Italiano, Angela Cioffi, Nicolas Penel, et al.
Anticancer Research|July 5, 2020
GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian CancerFrÉdÉric Selle, Pierre-Etienne Heudel, Anne-Claire Hardy-Bessard, et al.
Cancers|May 14, 2022
Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques NetworkHélène Bonsang-Kitzis, Nabilah Panchbhaya, Anne-Sophie Bats, et al.
The Lancet. Oncology|November 28, 2018
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 studyFlorence Duffaud, Olivier Mir, Pascaline Boudou-Rouquette, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2016
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trialRoman Rouzier, Sébastien Gouy, Frédéric Selle, et al.
Gynecologic Oncology|July 30, 2020
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)Félix Blanc-Durand, Claudia Lefeuvre-Plesse, Isabelle Ray-Coquard, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Thrombolysis|June 6, 2018
Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse eventsRomain Chopard, Guillaume Serzian, Sébastien Humbert, et al.
Medical Oncology (Northwood, London, England)|March 27, 2012
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumorsAntoine Adenis, Olivier Bouché, François Bertucci, et al.
Thrombosis Research|December 16, 2018
Prescription patterns of direct oral anticoagulants in pulmonary embolism: A prospective multicenter French registryRomain Chopard, Jean Noel Andarelli, Sébastien Humbert, et al.
Annals of Surgical Oncology|January 7, 2022
Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 PatientsBrice Paquette, Elsa Kalbacher, Frédéric Mercier, et al.
Cancer|November 3, 2011
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomasAntoine Italiano, Angela Cioffi, Nicolas Penel, et al.
Anticancer Research|July 5, 2020
GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian CancerFrÉdÉric Selle, Pierre-Etienne Heudel, Anne-Claire Hardy-Bessard, et al.
Cancers|May 14, 2022
Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques NetworkHélène Bonsang-Kitzis, Nabilah Panchbhaya, Anne-Sophie Bats, et al.
The Lancet. Oncology|November 28, 2018
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 studyFlorence Duffaud, Olivier Mir, Pascaline Boudou-Rouquette, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2016
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trialRoman Rouzier, Sébastien Gouy, Frédéric Selle, et al.
Gynecologic Oncology|July 30, 2020
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)Félix Blanc-Durand, Claudia Lefeuvre-Plesse, Isabelle Ray-Coquard, et al.
Pageof 6